Canyon Labs Bolsters Leadership with Strategic New Hires

Canyon Labs, recognized for its expertise in medical device and pharmaceutical testing and regulatory consulting, announced the addition of two pivotal leadership roles to its team on March 13, 2024, in Salt Lake City, UT. Kyle Kempf steps in as the Vice President of Sales and Marketing, and Carly Ames takes on the position of Senior Technical Business Development Executive. These appointments aim to enhance service offerings and business solutions for both existing and potential clients.

Kyle Kempf brings a notable decade-long career in engineering, with extensive experience across research and development (R&D), quality, operations, and technical sales. Kempf's diverse background in developing medical devices ranges from Class III implantable neurostimulators to Class I/II high volume disposables, equipping him with a unique perspective on customer needs and value delivery.

Carly Ames, with her profound background in the medical device industry, including manufacturing, R&D, quality assurance, operations, and sales, focuses on addressing Canyon Labs customers' unique needs to ensure successful outcomes. Her experience in leading microbiological and chemical testing further complements the company’s expertise.

According to Sarah Ptach, President of Canyon Labs, the strategic inclusion of Kempf and Ames is expected to fortify the company's position as an industry leader. Ptach highlights the anticipation for these new roles to cultivate growth, drive results for clients, and further distinguish Canyon Labs in the competitive landscape.